Can M-score be used to predict recurrence in IGM patients?

The treatment of IGM patients depends on the patient's symptoms. For this reason, a scoring system is needed to define the symptoms and interpret the response to treatment more objectively. The M-score is at a level that can meet this need. In the present study, the recurrence rate was found to be higher in patients with an initial M-score ≥ 5 than in patients with an M-score < 5, which leads us to the idea of initiating more aggressive treatment than observation or mono-treatment in patients with high M-scores at the time of presentation.